Capitalink Ltd. reports 4.99% of X Labs

Capitalink Ltd. amended its Schedule 13G to report beneficial ownership in X Labs Inc. The filing states Capitalink beneficially owns 667,034 shares, representing 4.99% of X Labs' 13,336,392 shares outstanding used for the calculation.

Rhea-AI Filing Summary

Capitalink Ltd. amended its Schedule 13G to report beneficial ownership in X Labs Inc. The filing states Capitalink beneficially owns 667,034 shares, representing 4.99% of X Labs' 13,336,392 shares outstanding used for the calculation. The filing counts 38,000 additional shares issuable upon exercise of warrants within 60 days and notes a 44,283-share warrant subject to a blocker provision.

Insights

Corporate Governance Analyst

Routine disclosure of sub-5% ownership with derivative interests.

Capitalink Ltd. reports beneficial ownership of 667,034 shares, equal to 4.99% based on 13,336,392 shares outstanding stated in the filing. The report includes 38,000 warrants exercisable within 60 days.

Filing preserves a blocker provision limiting exercise of an additional 44,283-share warrant to avoid exceeding 4.99%. Subsequent filings would show any change if warrants are exercised or additional acquisitions occur.

Capital Markets Specialist

Disclosure signals a passive stake under the 5% threshold.

The filing characterizes the position as passive: ownership is reported at 4.99% and the Schedule 13G/A framework applies. The report lists dispositive and voting power tied to 667,034 shares.

Because an exercise cap is documented, actual post-exercise ownership depends on future exercises and any blocking mechanics; cash‑flow treatment is not detailed in the excerpt.

Key Figures

Reported shares beneficially owned: 667,034 shares Percent of class: 4.99% Shares outstanding used for calculation: 13,336,392 shares +2 more

5 metrics

Reported shares beneficially owned 667,034 shares Beneficial ownership reported by Capitalink Ltd.

Percent of class 4.99% Calculated using 13,336,392 shares outstanding

Shares outstanding used for calculation 13,336,392 shares Issuer-provided outstanding share count used in the filing

Warrants exercisable within 60 days (counted) 38,000 shares Included in beneficial ownership calculation

Warrant with blocker provision 44,283 shares Exercise limited to avoid exceeding 4.99% beneficial ownership

Key Terms

Schedule 13G/A, beneficially owned, blocker provision, warrant

4 terms

Schedule 13G/A regulatory

"Amendment No. 1 ) X LABS INC. Common Stock"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amount beneficially owned: See items 5-11 of the cover pages"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

blocker provision legal

"blocker provision under which the Reporting Person does not have the right to exercise the warrant"

warrant financial

"issuable upon the exercise of warrants held by the Reporting Person"

A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Capitalink Ltd. report in X Labs (QXL)?

Capitalink Ltd. reports beneficial ownership of 667,034 shares, equal to 4.99%. The percentage is calculated using 13,336,392 shares outstanding provided by the issuer as of the filing.

Are there warrants or convertible instruments included in Capitalink's reported position?

Yes. The filing counts 38,000 shares issuable upon warrant exercise within 60 days toward beneficial ownership. It also discloses a separate 44,283-share warrant subject to a blocker provision.

What is the effect of the blocker provision mentioned in the filing?

The blocker provision prevents exercising a warrant to the extent it would cause beneficial ownership to exceed 4.99%. The filing cites this limit tied to the Reporting Person and related parties.

Does the Schedule 13G/A indicate active control or passive ownership by Capitalink?

The filing is presented as a Schedule 13G/A ownership disclosure, indicating a reporting framework for passive investors under the form's terms. It lists sole voting and dispositive power figures for the Reporting Person.

What outstanding share count does the filing use to compute the percentage?

The filing uses 13,336,392 shares of common stock as the issuer-provided figure for shares issued and outstanding as of the date referenced in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:15 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

QUANTUM X LABS INC.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

926711300

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 926711300

1

Names of Reporting Persons

Capitalink Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ISRAEL

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 667,034.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 667,034.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

667,034.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: * Percentage calculated based on 13,336,392 shares of common stock, $0.0001 par value per share (the "Shares"), of Quantum X Labs Inc. (the "Issuer") issued and outstanding as of the date hereof, which amount was provided to the Reporting Person by the Issuer.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: QUANTUM X LABS INC.
(b)	Address of issuer's principal executive offices: Atrium Tower, 2 Jabotinsky Street, Ramat Gan, Israel 5252903
Item 2.
(a)	Name of person filing: Capitalink Ltd.
(b)	Address or principal business office or, if none, residence: 20 Raoul Wallenberg Street, Tel Aviv, Israel 6971916
(c)	Citizenship: Israel
(d)	Title of class of securities: Common Stock, $0.0001 par value per share
(e)	CUSIP No.: 926711300
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein. Amount beneficially owned by the Reporting Person consists of (i) 629,034 Shares and (ii) the deemed ownership of an additional 38,000 Shares issuable upon the exercise of warrants held by the Reporting Person that the Reporting Person has the right to acquire within 60 days of the date of the report. Such amount does not include 44,283 Shares which may be acquired by the Reporting Person within 60 days of the date hereof through the exercise of a warrant, which includes a blocker provision under which the Reporting Person does not have the right to exercise the warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by the Reporting Person, together with the Reporting Person's affiliates, and any other persons acting as a group together with the Reporting Person or any of the Reporting Person's affiliates, of more than 4.99% of the Shares.
(b)	Percent of class: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
	(ii) Shared power to vote or to direct the vote: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
	(iii) Sole power to dispose or to direct the disposition of: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
	(iv) Shared power to dispose or to direct the disposition of: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capitalink Ltd.

Signature:	/s/ Lavi Krasney
Name/Title:	Lavi Krasney/Chief Executive Officer
Date:	05/15/2026